Tesofensine
From Wikipedia, the free encyclopedia
Tesofensine
|
|
Systematic (IUPAC) name | |
(2R,3S)-3-(3,4-dichlorophenyl)-2-ethoxymethyl- 8-methyl-8-azabicyclo[3.2.1]octane | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | C17H23Cl2NO |
Mol. mass | 328.28 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
Legal |
Routes | ? |
Tesofensine is a serotonin-noradrenaline-dopamine reuptake inhibitor, which also seems to increase the action of acetylcholine in the brain, probably due to downstream effects. It was originally researched for the treatment of Alzheimer's disease and Parkinson's Disease, but was subsequently dropped from development for these applications, and is now being researched for the treatment of obesity, presumably as an appetite suppressant. As of 2006 it was in Phase II trials for the treatment of obesity, and in September 2007 a Phase III trial was planned. [1]
[edit] References
- ^ Welcome to Psychotropics. Retrieved on 2008-01-11.
A diet pill that makes you feel full as soon as you start eating